
# üñ•Ô∏è BioHack I Hackathon ‚Äî Event Notes 

Structured notes capturing lectures, daily activities, and my multi-omics challenge participation in a professional, readable format.

---

## üìÖ Hackathon Schedule & Highlights

**Institution:** German International University (GIU), Administrative Capital, Cairo, Egypt  
**Dates:** 23‚Äì25 June 2024   
**Coordinators:** Prof. Dr. Nabila Hamdi & Prof. Dr. Mohamed Hamed

### **Day 1 ‚Äì Sunday, 23 June 2024**  
- **Welcome & Introduction:**  
  - Prof. Dr. Slim Abdennadher (GIU President)  
  - Prof. Dr. Nabila Hamdi (GARN-CLS Representative , GIU)  
  - Prof. Dr. Mohamed Hamed (GARN-CLS Coordinator, GIU)  

- **Keynote Talk:**  
  *Applications of Machine Learning to Predict Non-Canonical Translation Start Sites and Substrates of Membrane Transporters*  
  ‚Äî Prof. Dr. Volkhard Helms (**Saarland University, Saarbr√ºcken, Germany**)  

  **Notes:**  
  - ML models for predicting non-canonical translation start sites  
  - Integration of sequence & structural features  
  - Importance of feature selection & cross-validation  

- Hackathon kickoff & team formation  

---
### **Day 2 ‚Äì Monday, 24 June 2024**  
- Hackathon activities & mentorship sessions  

- **Keynote Talk:**  
  *Drug Design & Drug Repurposing in Oncology*  
  - Prof. Dr. Kais Ghedira (**Institut Pasteur, Tunis, Tunisia**)  
  - Prof. Dr. Oussema Khamessi (**University of Manouba & Institut Pasteur, Tunis, Tunisia**)  

  **Notes:**  
  - Drug repurposing strategies for oncology  
  - Bioinformatics approaches to predict drug-target interactions  
  - Integration of multi-omics data for drug response prediction  

- Progress updates by all teams  

---
### **Day 3 ‚Äì Tuesday, 25 June 2024**  
- Continuation of hackathon activities  
- Final team presentations (Teams 1‚Äì12)  
- Certificates & closing ceremony  
---

## üìÇ Hackathon Challenges Overview

| #  | Challenge Title                                              | Mentors / Supervisors                                                |
| -- | ------------------------------------------------------------ | -------------------------------------------------------------------- |
| 1  | Microbiome Biomarker Identification                          | Dr. Amira Metwaly, Dr. Ahmed Sayed                                   |
| 2  | Multi-modal Fusion of Radiomics & Genomics in Cancer         | Alaa Amr, Prof. Dr. Shereen Afifi, Prof. Dr. Mohamed Hamed           |
| 3  | Federated Random Forest for Biomedical Data Analysis         | Dr. Youngjun Park, Dr. Miriam Cindy Maurer                           |
| 4  | NPM-1 in Breast & Prostate Cancer Metastasis                 | Prof. Dr. Hiba El Hajj, Prof. Dr. Mohamed Hamed                      |
| 5  | Virtual & Augmented Reality for Bioinformatics Visualization | Prof. Dr. Slim Abdennadher, VR Team GIU                              |
| 6  | From RNA Reads to Drug Leads (Neurodegeneration)             | Prof. Dr. Kais Ghedira, Prof. Dr. Oussema Khamessi, Feryel Boughanmi |
| 7  | Single-Cell RNA-Seq Best Practice                            | Dr. Asmaa Reda, Prof. Dr. Fouzia Radouani                            |
| 8  | Mendelian Randomization in ALS                               | Dr. Veronika Klose, Prof. Dr. Nabila Hamdi                           |
| 9  | Multi-omics for Pan-Cancer Risk Scores                       | Prof. Dr. Noha A. Yousri, Nesma Lotfy                                |
| 10 | Deep Neural Networks for Spatial Transcriptomics             | Mariam Wael, Prof. Dr. Mohamed Hamed, Prof. Dr. Mohamed A. Salem     |
| 11 | Micro Optical Sensors for Pharmacogenomics                   | Prof. Dr. Eng. Amir Roushdy                                          |
| 12 | Epigenetic Signatures & Prognostic Gene Expression Profiles  | Dr. Salma M. Abozeid                                                 |
| 13 | Benchmarking ML Methods on scRNA-Seq Data                    | Dr. Sally Ibrahim                                                    |

---

## üî¨ My Challenge ‚Äî Overview

**Title:** Unraveling Epigenetic Signatures Associated with Prognostic Gene Expression Profiles
**Mentor:** Dr. Salma M. Abozeid, Faculty of Pharmacy & Biotechnology, GUC, Egypt

**Objective:**

* Integrate RNA-seq and ChIP-seq datasets to uncover epigenetic signatures linked to cancer prognosis
* Analyze enhancers, super-enhancers, transcription factor binding, and construct gene regulatory networks

**Skills Applied:**

* R programming & data visualization
* RNA-seq & ChIP-seq analysis
* Cytoscape for GRN construction
* IGV for genomic region exploration
* Motif & TFBS identification

**Methodology:**

1. Data preprocessing & QC
2. DEG identification
3. ChIP-seq peak annotation & visualization
4. Active regulatory region analysis (enhancers & SEs)
5. GRN construction
6. Motif & TFBS discovery
7. Integration for prognostic biomarker identification

**Expected Outcomes:**

* Visualized genomic regions
* DEGs associated with regulatory elements
* GRNs & TF identification
* Integrated multi-omics interpretation for cancer prognosis

---

## üß† Key Takeaways

* Hands-on experience from raw multi-omics data to final biological insights
* Integration of transcriptomics & epigenomics is crucial for understanding cancer mechanisms
* Strengthened skills in **R, Cytoscape, IGV, multi-omics analysis**
* Mentorship facilitated **workflow mastery & scientific problem-solving**
